Alnylam Pharmaceuticals
ALNY
#581
Rank
C$49.28 B
Marketcap
$382.10
Share price
2.75%
Change (1 day)
72.08%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Total assets

Total assets on the balance sheet as of June 2024 : C$5.59 Billion

According to Alnylam Pharmaceuticals 's latest financial reports the company's total assets are C$5.59 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Alnylam Pharmaceuticals - Total assets on balance sheet (from 2003 to 2024)

Total assets by year

Year Total assets Change
2023-12-31C$5.07 B5.56%
2022-12-31C$4.81 B3.64%
2021-12-31C$4.64 B6.88%
2020-12-31C$4.34 B38.87%
2019-12-31C$3.12 B45.82%
2018-12-31C$2.14 B-14.46%
2017-12-31C$2.50 B47.78%
2016-12-31C$1.69 B-11.77%
2015-12-31C$1.92 B53.52%
2014-12-31C$1.25 B179.87%
2013-12-31C$0.44 B56.57%
2012-12-31C$0.28 B-0.3%
2011-12-31C$0.28 B-27.05%
2010-12-31C$0.39 B-22.39%
2009-12-31C$0.50 B-24.9%
2008-12-31C$0.67 B36.91%
2007-12-31C$0.49 B76.28%
2006-12-31C$0.27 B144.05%
2005-12-31C$0.11 B44.21%
2004-12-31C$79.4 M73.97%
2003-12-31C$45.63 M79.36%
2002-12-31C$25.44 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
C$1.23 B-77.96%๐Ÿ‡บ๐Ÿ‡ธ USA
C$50.34 B 800.00%๐Ÿ‡บ๐Ÿ‡ธ USA
C$4.77 B-14.60%๐Ÿ‡บ๐Ÿ‡ธ USA
C$2.76 B-50.62%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.14 B-97.40%๐Ÿ‡บ๐Ÿ‡ธ USA
C$136.01 B 2,331.77%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
C$194.03 B 3,369.02%๐Ÿ‡ซ๐Ÿ‡ท France
C$57.66 B 930.97%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel